23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Two Years of Calorie Restriction and Cardiometabolic Risk Factors

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          For several cardiometabolic risk factors, values considered within normal range are associated with increased risks of cardiovascular morbidity and mortality. However, very little is known about the short- and long-term effects of caloric restriction (CR) with adequate nutrition on these risk factors in healthy lean or slightly overweight young and middle-aged individuals.

          METHODS

          Cardiometabolic risk factor responses to a prescribed 25% CR diet for 2-years were evaluated in a multicenter randomized controlled trial in 218 young and middle-aged (21 to 50 y), healthy non-obese (body mass index 22 to 27.9 kg/m 2) men and women.

          RESULTS

          Over two years, participants in the CR group achieved 11.9% CR and a sustained 10% weight loss, of which 71% was fat mass loss. CR caused a significant and persistent reduction of all measured conventional cardiometabolic risk factors, including LDL-cholesterol, total cholesterol to HDL-cholesterol ratio, systolic and diastolic blood pressure. In addition, CR resulted in a significant improvement in C-reactive protein, glucose tolerance, insulin sensitivity index, and metabolic syndrome score relative to control. A secondary analysis revealed the responses to be robust after controlling for relative weight loss changes.

          CONCLUSIONS

          Two years of moderate caloric restriction significantly reduced multiple cardiometabolic risk factors in young, non-obese men and women. These findings suggest the potential for significant cardiovascular advantage of practicing moderate CR in young and middle-aged healthy individuals, and they offer promise for significant long-term population health benefits.

          Related collections

          Author and article information

          Journal
          101618821
          41837
          Lancet Diabetes Endocrinol
          Lancet Diabetes Endocrinol
          The lancet. Diabetes & endocrinology
          2213-8587
          2213-8595
          22 July 2019
          11 July 2019
          September 2019
          01 September 2020
          : 7
          : 9
          : 673-683
          Affiliations
          [1 ]Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
          [2 ]Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.
          [3 ]Duke Center for Aging and Human Development, School of Medicine, Duke University.
          [4 ]Jean Mayer, US Department of Agriculture, Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.
          [5 ]Pennington Biomedical Research Center, Baton Rouge, LA, USA.
          [6 ]Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
          [7 ]Center for Translational Research on Inflammatory Diseases, Michael E DeBakey VA Medical Center, and Baylor College of Medicine, Houston, TX, USA
          [8 ]Rho Federal Systems, Chapel Hill, NC, USA.
          [9 ]Department of Clinical and Experimental Sciences, Brescia University, Brescia, Italy.
          [10 ]School of Medicine and Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.
          Author notes

          Contributions of Authors:

          Study design and collection of study data: WEK, CFP, SKD, LMR, DTV, JR, SBR, ER, JOH

          Drafted and revised the manuscript: WEK

          Contributed to drafting of the manuscript: KMH, LF, CFP

          Performed statistical analyses, reviewed and contributed to the editing of the manuscript: MB, CFP, JP

          Reviewed the manuscript and approval of contents: WEK, MB, KMH, CFP, SKD, LMR, DTV, JR, SBR, ER, JOH, LF.

          Corresponding Author:William E. Kraus, MD, Duke University School of Medicine, 300 N. Duke St., Durham, NC 27701, 919-681-6733, william.kraus@ 123456duke.edu
          Article
          PMC6707879 PMC6707879 6707879 nihpa1535351
          10.1016/S2213-8587(19)30151-2
          6707879
          31303390
          bb86ab9e-c606-4be3-bf56-9345168cec92
          History
          Categories
          Article

          Comments

          Comment on this article